FDA Clearance Tracker · K252527
Surfacer Inside-Out Access Catheter System
Last checked: Nov 19, 2026Latest source record: Sep 10, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Sep 10, 2025
Unknown
Time to decision
30 days
Received Aug 11, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K252527
- Device name
- Surfacer Inside-Out Access Catheter System
- Applicant
- Merit Medical System, Inc.
- Applicant location
- South Jordan, UT
- Received
- Aug 11, 2025
- Decided
- Sep 10, 2025
- Decision
- Unknown
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1342
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QJH. The earliest in FDA's data is DEN190038, decided Feb 10, 2020.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K252527
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Merit Medical System, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SCOUT MD Surgical Guidance SystemBreakthrough510(k)
K231468 · Decided Feb 12, 2024 · 266 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
- Maestro Microcatheter510(k)
K230636 · Decided Mar 30, 2023 · 23 days after receipt
Device type: Catheter, Continuous Flush (KRA) · Cardiology
K212817 · Decided Dec 15, 2021 · 103 days after receipt
Device type: Device, Vascular, For Promoting Embolization (KRD) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.